INVESTOR PRESENTATION Patented Technology for

Enhanced Delivery to the Skin CONFIDENTIAL 2018

T H I S P R E S E N TAT I O N B E L O N G S E X C L U S I V E LY T O O V AT I O N S C I E N C E I N C . I T D O E S N O T I M P LY A N O F F E R I N G O F S E C U R I T I E S .

F O R W A R D - L O O K I N G S TAT E M E N T S :

T H I S P R E S E N TAT I O N C O N TA I N S F O R W A R D - L O O K I N G S TAT E M E N T S W I T H I N T H E M E A N I N G O F S E C T I O N 2 7 A O F T H E S E C U R I T I E S A C T O F 1 9 3 3 A N D

S E C T I O N 2 1 E O F T H E S E C U R I T I E S E X C H A N G E A C T O F 1 9 3 4 . A C T U A L R E S U LT S C O U L D D I F F E R M AT E R I A L LY F R O M T H O S E P R O J E C T E D I N T H E F O R W A R D - L O O K I N G S TAT E M E N T S A S A R E S U LT O F T H E R I S K - R E L AT E D

F A C T O R S S E T F O R T H H E R E I N .

N O T F O R D I S S E M I N AT I O N I N T H E U S A

SAFE HARBOR

STATEMENT

CSE:OVAT

OVATION SCIENCE INC.

Ovation Science Inc. (“OVATION”), is a skincare research and development company with a patented technology backed by

over 20 years of R&D.

We have the exclusive world-wide rights to all cannabis and hemp seed oil products (hemp and marijuana) formulated with patented skin delivery

technology Invisicare®.

Our business model is to develop and license out skincare formulations powered by Invisicare® technology to cannabis companies globally.

OVATION IS UNIQUE FROM OTHER INFUSED PRODUCT COMPANIES AS WE

LEVERAGE OUR EXPERTISE IN THE PHARMACEUTICAL INDUSTRY TO DEVELOP HIGHLY EFFECTIVE, PATENT-PROTECTED PRODUCTS;

& WE HAVE THE RESULTS TO PROVE IT.

NOTE: OVATION does not sell or distribute any products that are in violation of the United States Controlled

Substances Act (US.CSA). The company does sell its Invisicare polymer to its licensees

CSE:OVAT

OVATION SCIENCE INC.

CSE:OVAT

Stock Symbol: OVATION trades on the Canadian Securities Commission under the symbol CSE:OVAT. Trading Date: November 16, 2018 Market Cap: $6.9 million Number of Issued Shares: 23.2 million IPO Share Price: $.30

OVATION SCIENCE INC.

INVESTMENT HIGHLIGHTS - CSE:OVAT

Invisicare®: a high performance skin delivery technology which enhances the delivery of ingredients to and through the skin. Patented in 11 countries including Canada & USA, Australia, Europe and Asia.

PATENTED TECHNOLOGY With 20 YRS of R&D

1. Canopy Growth Corporation (TSX:WEED), one of the world’s largest cannabis company by market cap;

2. Lighthouse Strategies LLC: a private US-based company that holds multiple Nevada and California licenses & has aggressive US expansion plans.

KEY LICENSES ALREADY In PLACE

Revenue is generated from a combination of: Product Development fees Licensing fees Royalties based on sales of product by licensees The sale of Invisicare® polymers to licensees

MULTIPLE PRONGED BUSINESS MODEL With LOW COGS

Over 80 years of combined pharmaceutical product development expertise Ovation’s highly experienced Management team & Board of Directors has expertise in pharmaceutical development, public markets, finance & marketing.

EXPERIENCED MANAGEMENT TEAM

CSE:OVAT

KEY EXECUTIVES & BOARD OF DIRECTORS OVATION SCIENCE INC.

OVATION has a team with decades of experience in business development, product research & development, and financial markets

Terry Howlett

President, Director

Co-Founder

Doreen McMorran

VP BD, Director

Co-Founder

Logan Anderson

CFO, Director

Ian Howard

Director

Joan Chypyha

Director

Founder of Skinvisible Pharmaceuticals, Inc. Has over 35 years of entrepreneurial, business management & public market initialization experience.

Brings 25+ yrs of experience in the medical & pharmaceutical industry, specifically in the areas of strategic planning, sales & marketing of dermatology products.

Dave Ryan

Head of IR, Director

James Roszell, PhD, Head of Product Development, is an doctoral chemist with over 40 yrs experience in product formulation, experimental design, analysis, and method validation.

Has 40+ years of extensive experience in: international dermatology marketing & education, advertising, sponsorship with private, Fortune 500 companies & government.

Has over25 years of experience in the pharmaceutical industry in various senior management positions: President & GM (Canada) for TSX company & GM of NASDAQ companies & >20 licensing deals & product launches to her credit.

For 30+ years has held director & senior executive officer positions in numerous public companies due to his considerable financial and management expertise.

Has extensive experience in investment and public markets. For the past 20 years he has been influential in bringing multiple Initial Public Offerings to market.

CSE:OVAT

INVISICARE – THE UNIQUE STORY

Invisicare is a powerful yet flexible combination of polymers (like “tubes”) that incorporate key ingredients within its structure. It enhances how cannabinoids are delivered to and through the skin:

• Increases the release of cannabinoids & delivers increased levels to & through your skin

Super Charges the Delivery of Cannabinoids:

• Forms a protective bond that holds ingredients on your skin resisting both rub-off & wash-off while allowing your skin to still breathe naturally

Skin Binding:

• Has a stabilizing effect on ingredients so they don’t break down & are available to do what they are intended to do

Stabilizes Ingredients:

• Invisicare improves your skin barrier function by retaining water / moisture in your skin & preventing damage from outside elements & toxins

Increases Moisture Levels:

• Ovation formulations do not contain alcohol, parabens, waxes or other organic solvents

Less Additives:

CSE:OVAT

THE PRODUCTS & THE RESULTS

DISRUPTIVE POSITIONING OVATION products are game changers in the infused cannabis marketplace,

replacing the “homemade” persona of current topical products with science-based, efficacious products that will benefit consumers around the globe.

OVATION products releases more CBD and THC to the skin (40% vs 3%). OVATION’s transdermal product was showed a 81% penetration (vs average penetration of other products @10-25%) . (Results of a Franz Cell Diffusion Analysis)

THE RESULTS

TOPICAL DELIVERY 3% vs 40% (Ovation) @ 2Hrs

TRANSDERMAL PENETRATION 10%-25% vs 81% (Ovation) @ 6 Hrs % Comparison

of Active CBD Delivery

CSE:OVAT

CURRENT LICENSEES

• A world-leading cannabis company with multiple brands, state-of-the-art production facilities & a $7 billion market cap.

• RIGHTS INCLUDE:

Building a global brand is Canopy’s strategy for OVATION products including international expansion. (Canopy has entered Germany, Australia, Spain, Chile and Brazil markets).

• A Nevada/California-based cannabis marketing company with multiple successful brands & other cannabis related enterprises for which they have generated record breaking online followings.

• RIGHTS INCLUDE:

They have a state-of-the art cannabis facility in San Diego (cultivation, dispensary and production) which will also house ARC, a cannabis medical research center which is supported by Lighthouse.

• Building momentum for their brands is Lighthouse’s expertise and strategy. They leverage their infrastructure for economies of scale. They have an aggressive expansion plan which will take OVATION formulated products across the USA both within and outside of licensed dispensaries.

Hemp seed oil

Exclusive for Canada & USA + First Rights globally excluding China

• Development fees • License fees • Royalties

Cannabinoids

Exclusive for Canada + First Rights globally excluding US dispensaries

Cannabinoids Exclusive for USA in dispensaries

•Access to R&D facility • Royalties

CBD only products Non-exclusive for USA

CSE:OVAT

FIRST PRODUCTS LAUNCHED

• May, 2018 was the official launch in the United States of two of OVATION’s products: BASKiN Extended Wellness Cream and BASKiN + Extended Wellness Cream;

• Retail sales of ~$650,000 in first 4 months of launch (Two products: Nevada only)

• An expanded BASKiN product line will launch in Q4 of 2018 along with expansion into other states

I have had IBD associated arthritis for the past 6 years, and live with some degree of pain almost all the time. I have tried numerous prescription drugs to no avail. When I had a terrible flare up about three weeks ago, I tried your product. I have been using it now for two weeks and within a half hour have found that the pain has significantly subsided. I have been able to resume my daily routine. (Roshana – Brooklyn)

I want to extend my thanks and congratulations for creating such a fine product. I have suffered osteoarthritis in my knees for almost 30 years. I have tried everything, short of knee replacements, that was offered by the pharmaceutical and natural products industry. The Baskin+ cream gave me more relief overnight than I have ever had from any other product or treatment. It sounds strange, but I really look forward to each application. (Jim – Brooklyn)

This past weekend my wife and I were in Las Vegas and purchased the BASKiN cream. She has had various types of pain management and nothing worked as well as this cream. (Don – New York)

TESTIMONIALS:

www.baskinessentials.com

CSE:OVAT

I purchased two of your “Extended Wellness Cream” 400mg of CBD while I was in Las Vegas. This has been the only product that has helped my wife, who has a cervical fusion from C2 down to T1. (Chad – San Diego)

NEW PRODUCT INTRODUCTIONS in Q4

• Lighthouse is expanding its BASKiN Essentials product line with three new products in Q4 of 2018 in Nevada and California

• Introduction of first THC creams for dispensaries

• Negotiating with 6 additional states for rapid expansion in Q1 2019 and an additional 20 states for 2019

Contains THC & CBD (10:1 & 1:10)

CSE:OVAT

FUTURE EXPANSION

• OVATION will enter the animal health market with CBD/THC powered topical and transdermal products to help animals with pain / arthritis, inflammation, skin irritation / dry skin, and even insect bites.

• Currently the prescription pet market generates almost $14 billion in sales in the USA.

• Synthetic cannabinoids are “laboratory-derived” therefore providing 100% consistency; just like a prescription drug (products that require FDA/Health Canada approvals).

CSE:OVAT

• OVATION’s R&D lab has developed 20 additional topical and transdermal products that are ready to launch.

• A complete CBD beauty line is part of the 2019 launch plans which includes a series of 5 anti-aging, and moisturizing products.

• OVATION is pursuing potential pharmaceutical companies that use synthetic cannabis for topical and transdermal products.

Short & Long Term Revenue in progress

with 2 leading licensees

Market has exponential growth

& global

prospects

Game changing pharmaceutical grade products

unique & in demand

Experienced team of executives & directors

INVESTMENT SUMMARY OVATION SCIENCE INC.

TRADING ON THE CSE: STOCK SYMBOL: OVAT

THANK YOU

For more information contact:

Terry Howlett, President & CEO Email: terry@ovationscience.com Or Dave Ryan, Director, Investor Relations Email: dave@ovationscience.com For Business Development inquires contact: Doreen McMorran, Vice President doreen@ovationscience.com

CSE:OVAT